Free Trial

Ovid Therapeutics (OVID) Insider Trading & Ownership

Ovid Therapeutics logo
$1.02 +0.01 (+0.99%)
(As of 12/19/2024 05:49 PM ET)

Ovid Therapeutics (NASDAQ:OVID) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.30%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$50,364.48
Number Of
Insiders Selling
(Last 12 Months)
0
Get OVID Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ovid Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

OVID Insider Buying and Selling by Quarter

Ovid Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/18/2024Jeremy M LevinCEOBuy18,248$2.76$50,364.48  
(Data available from 1/1/2013 forward)

OVID Insider Trading Activity - Frequently Asked Questions

The list of insiders at Ovid Therapeutics includes Jason Tardio, and Jeremy M Levin. Learn more on insiders at OVID.

13.30% of Ovid Therapeutics stock is owned by insiders. Learn more on OVID's insider holdings.

The following insider purchased OVID shares in the last 24 months: Jeremy M Levin ($50,364.48).

Insiders have purchased a total of 18,248 OVID shares in the last 24 months for a total of $50,364.48 bought.

Ovid Therapeutics Key Executives

  • Dr. Jeremy Max Levin Ba Zoology (Age 71)
    Dphil, Mb Bchir, President, CEO & Chairman
    Compensation: $1.03M
  • Mr. Jeffrey A. Rona (Age 56)
    Chief Business and Financial Officer
    Compensation: $761.24k
  • Mr. Thomas Michael Perone J.D. (Age 59)
    M.B.A., General Counsel, Chief Compliance Officer & Corporate Secretary
    Compensation: $745.71k
  • Mr. Jason Tardio M.B.A. (Age 47)
    Chief Operating Officer
    Compensation: $652.84k
  • Mr. Simon D. Kelner (Age 50)
    Chief Human Resources Officer
  • Dr. Dirk Haasner (Age 59)
    Senior Vice President of Global Manufacturing & CMC QA
    Compensation: $416.95k
  • Dr. Todd F. Baumgartner M.D.
    M.P.H., Senior Vice President of Regulatory Affairs
  • Dr. Julia Tsai Ph.D. (Age 49)
    Senior Vice President of Clinical Development
  • Ms. Meg Alexander
    Chief Strategy Officer
  • Dr. Manoj Malhotra M.D.
    Chief Medical Officer


This page (NASDAQ:OVID) was last updated on 12/20/2024 by MarketBeat.com Staff
From Our Partners